Skip to main content

Table 1 Patient characteristics

From: Association between the number of coadministered P-glycoprotein inhibitors and serum digoxin levels in patients on therapeutic drug monitoring

Characteristic TDM patients N= 618
Age (years)* 84 (24–99)
P-creatinine (mmol/L)* 100 (36–598)
Daily digoxin dose (mg)* 0.13 (0.04–0.5)
Concomitant drugs* 5 (1–21)
Patients below therapeutic range (< 1.2 nmol/L) 263
Patients within therapeutic range (1.2–2.5 nmol/L) 317
Patients above therapeutic range (> 2.5 nmol/L) 38
  1. *Median (range). TDM = therapeutic drug monitoring.